AI assistant
ProQR Therapeutics N.V. — Proxy Solicitation & Information Statement 2026
May 4, 2026
33579_ffr_2026-05-04_4bac1e53-f062-40d4-b18d-da1f9105c59c.zip
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
6-K 1 tm2613307d1_6k.htm FORM 6-K
Field: Rule-Page
Field: /Rule-Page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
For the month of May 2026
Commission File Number: 001-36622
PROQR THERAPEUTICS N.V.
Zernikedreef 9
2333 CK Leiden
The Netherlands
Tel: +31 88 166 7000
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Field: Rule-Page
Field: /Rule-Page
Field: Page; Sequence: 1
Field: /Page
On May 4, 2026, ProQR Therapeutics N.V. issued a press release titled “ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026” and made available to its shareholders certain other materials in connection with such meeting.
Such materials are attached as exhibits to this Report of Foreign Private Issuer on Form 6-K and are incorporated by reference herein.
Field: Page; Sequence: 2
Field: /Page
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| /s/ Dennis Hom |
|---|
| Dennis Hom |
| Chief Financial Officer |
Field: Page; Sequence: 3
Field: /Page
INDEX TO EXHIBITS
| Number | Description |
|---|---|
| 99.1 | Press Release of ProQR Therapeutics N.V. dated May 4, |
| 2026. | |
| 99.2 | Notice of the 2026 Annual General Meeting of Shareholders. |
| 99.3 | Explanatory Notes to the Agenda of the 2026 Annual |
| General Meeting of Shareholders. | |
| 99.4 | Proposed Form of Deed of Amendment of Articles |
| of Association (Dutch Original). | |
| 99.5 | Proposed Form of Deed of Amendment of Articles |
| of Association (English Translation). | |
| 99.6 | Proxy |
| Form. |
Field: Page; Sequence: 4; Options: Last
Field: /Page